These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 39021828)

  • 1. Virtual screening, molecular docking, MD simulation studies, DFT calculations, ADMET, and drug likeness of Diaza-adamantane as potential MAPK
    Gheidari D; Mehrdad M; Hoseini F
    Front Pharmacol; 2024; 15():1360226. PubMed ID: 39021828
    [No Abstract]   [Full Text] [Related]  

  • 2. Investigation of the New Inhibitors by Sulfadiazine and Modified Derivatives of α-D-glucopyranoside for White Spot Syndrome Virus Disease of Shrimp by In Silico: Quantum Calculations, Molecular Docking, ADMET and Molecular Dynamics Study.
    Kumer A; Chakma U; Rana MM; Chandro A; Akash S; Elseehy MM; Albogami S; El-Shehawi AM
    Molecules; 2022 Jun; 27(12):. PubMed ID: 35744817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, docking, MD simulation, ADMET, drug likeness, and DFT studies of novel furo[2,3-b]indol-3a-ol as promising Cyclin-dependent kinase 2 inhibitors.
    Gheidari D; Mehrdad M; Bayat M
    Sci Rep; 2024 Feb; 14(1):3084. PubMed ID: 38321062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of novel PI3Kδ inhibitors by docking, ADMET prediction and molecular dynamics simulations.
    Liu YY; Feng XY; Jia WQ; Jing Z; Xu WR; Cheng XC
    Comput Biol Chem; 2019 Feb; 78():190-204. PubMed ID: 30557817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigating a Library of Flavonoids as Potential Inhibitors of a Cancer Therapeutic Target MEK2 Using in Silico Methods.
    AlZahrani WM; AlGhamdi SA; Sohrab SS; Rehan M
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenolic compounds of Theobroma cacao L. show potential against dengue RdRp protease enzyme inhibition by In-silico docking, DFT study, MD simulation and MMGBSA calculation.
    Huq AKMM; Roney M; Dubey A; Nasir MH; Tufail A; Aluwi MFFM; Ishak WMW; Islam MR; Tajuddin SN
    PLoS One; 2024; 19(3):e0299238. PubMed ID: 38483871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Silico Molecular Docking Analysis of Karanjin against Alzheimer's and Parkinson's Diseases as a Potential Natural Lead Molecule for New Drug Design, Development and Therapy.
    Gnanaraj C; Sekar M; Fuloria S; Swain SS; Gan SH; Chidambaram K; Rani NNIM; Balan T; Stephenie S; Lum PT; Jeyabalan S; Begum MY; Chandramohan V; Thangavelu L; Subramaniyan V; Fuloria NK
    Molecules; 2022 Apr; 27(9):. PubMed ID: 35566187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational Insights into Chromene/pyran Derivatives: Molecular Docking, ADMET Studies, DFT Calculations, and MD Simulations as Promising Candidates for Parkinson's Disease.
    Rani A; Aslam M; Khan J; Pandey G; Singh P; Maharia RS; Nand B
    Chem Biodivers; 2024 Aug; 21(8):e202400920. PubMed ID: 38818615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational Screening Using a Combination of Ligand-Based Machine Learning and Molecular Docking Methods for the Repurposing of Antivirals Targeting the SARS-CoV-2 Main Protease.
    Yuda GPWC; Hanif N; Hermawan A
    Daru; 2024 Jun; 32(1):47-65. PubMed ID: 37907683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Leading Compounds from
    Islam MN; Pramanik MEA; Hossain MA; Rahman MH; Hossen MS; Islam MA; Miah MMZ; Ahmed I; Hossain AM; Haque MJ; Islam AM; Ali MN; Jahan RA; Haque ME; Rahman MM; Hasan MS; Rahman MM; Kabir MM; Basak PM; Sarkar MAM; Islam MS; Rahman MR; Prodhan AA; Mosaddik A; Haque H; Fahmin F; Das HS; Islam MM; Emtia C; Gofur MR; Liang A; Akbar SMF
    Euroasian J Hepatogastroenterol; 2023; 13(2):89-107. PubMed ID: 38222948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the Natural Compounds in Flavonoids for Their Potential Inhibition of Cancer Therapeutic Target MEK1 Using Computational Methods.
    AlZahrani WM; AlGhamdi SA; Zughaibi TA; Rehan M
    Pharmaceuticals (Basel); 2022 Feb; 15(2):. PubMed ID: 35215307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemical Characterization,
    Ansari JA; Ahmad MK; Fatima N; Azad I; Mahdi AA; Satyanarayan GNV; Ahmad N
    Anticancer Agents Med Chem; 2022; 22(20):3416-3437. PubMed ID: 35125087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural insights into pharmacophore-assisted in silico identification of protein-protein interaction inhibitors for inhibition of human toll-like receptor 4 - myeloid differentiation factor-2 (hTLR4-MD-2) complex.
    Mishra V; Pathak C
    J Biomol Struct Dyn; 2019 May; 37(8):1968-1991. PubMed ID: 29842849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Docking, Drug-Likeness and ADMET Analysis, Application of Density Functional Theory (DFT) and Molecular Dynamics (MD) Simulation to the Phytochemicals from Withania Somnifera as Potential Antagonists of Estrogen Receptor Alpha (ER- α).
    Hossain A
    Curr Comput Aided Drug Des; 2021; 17(6):797-805. PubMed ID: 32748755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening of potential inhibitors of
    Tewari D; Rawat K; Bisht A; Almoyad MAA; Wahab S; Chandra S; Pande V
    J Biomol Struct Dyn; 2023 Nov; ():1-18. PubMed ID: 37922151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-silico Design, ADMET Screening, Prime MM-GBSA Binding Free Energy Calculation and MD Simulation of Some Novel Phenothiazines as 5HT6R Antagonists Targeting Alzheimer's Disease.
    V P; A M; N R
    Curr Comput Aided Drug Des; 2024 Jan; ():. PubMed ID: 38204222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A combination of virtual screening, molecular dynamics simulation, MM/PBSA, ADMET, and DFT calculations to identify a potential DPP4 inhibitor.
    Zare F; Ataollahi E; Mardaneh P; Sakhteman A; Keshavarz V; Solhjoo A; Emami L
    Sci Rep; 2024 Apr; 14(1):7749. PubMed ID: 38565703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational repurposing approach for targeting the critical spike mutations in B.1.617.2 (delta), AY.1 (delta plus) and C.37 (lambda) SARS-CoV-2 variants using exhaustive structure-based virtual screening, molecular dynamic simulations and MM-PBSA methods.
    Ebrahimi M; Karami L; Alijanianzadeh M
    Comput Biol Med; 2022 Aug; 147():105709. PubMed ID: 35728285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repurposing of phyto-ligand molecules from the honey bee products for Alzheimer's disease as novel inhibitors of BACE-1: small molecule bioinformatics strategies as amyloid-based therapy.
    Nisa N; Rasmita B; Arati C; Uditraj C; Siddhartha R; Dinata R; Bhanushree B; Bidanchi RM; Manikandan B; Laskar SA; Abinash G; Pori B; Roy VK; Gurusubramanian G
    Environ Sci Pollut Res Int; 2023 Apr; 30(17):51143-51169. PubMed ID: 36808033
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Umar AB; Uzairu A
    J Taibah Univ Med Sci; 2023 Oct; 18(5):933-946. PubMed ID: 36875340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.